| Jon G Meine, MD | |
|
9500 Euclid Ave, Cleveland, OH 44195-0001 | |
| (800) 223-2273 | |
| Not Available |
| Full Name | Jon G Meine |
|---|---|
| Gender | Male |
| Speciality | Dermatology |
| Experience | 30 Years |
| Location | 9500 Euclid Ave, Cleveland, Ohio |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1811953045 | NPI | - | NPPES |
| 2115286 | Medicaid | OH |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207N00000X | Dermatology | 35074614M (Ohio) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Cleveland Clinic | Cleveland, OH | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Cleveland Clinic Foundation | 1850203555 | 5690 |
News Archive
Pressure BioSciences, Inc. and Target Discovery, Inc.,, today announced a strategic product licensing, manufacturing, co-marketing, and collaborative research and development agreement. Under the terms of the Agreement, PBI has been licensed by TDI to manufacture and sell a highly innovative line of chemicals used in the preparation of tissues for scientific analysis.
A provocative new study has found that people who respond to stressful situations with angry facial expressions, rather than fearful expressions, are less likely to suffer such ill effects of stress as high blood pressure and high stress hormone secretion.
The H1N1 (swine) flu is blamed for 557 deaths in Brazil, "making it the country with the highest number of fatalities in the world from the disease," according to the country's health ministry, Agence France-Presse reports. "Brazil's health ministry said in a statement the government was freeing up one billion dollars to buy 73 million doses of a new vaccine being developed against swine flu, as well as Tamiflu stocks, hospital equipment and diagnostic gear," the news service writes (8/26).
Exelixis, Inc. announced today that thirteen abstracts related to the company's development candidates have been accepted for presentation at the 2009 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics, which is being held November 15-19 in Boston. Interim data from ongoing phase 1 clinical trials of XL147 and XL765 will be reported in four poster presentations.
Scientists in The Netherlands have revealed how gluten plays a role in the development of a rare form of cancer, for some people with coeliac disease.
› Verified 7 days ago
| Entity Name | The Cleveland Clinic Foundation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1679525919 PECOS PAC ID: 1850203555 Enrollment ID: O20031103000049 |
News Archive
Pressure BioSciences, Inc. and Target Discovery, Inc.,, today announced a strategic product licensing, manufacturing, co-marketing, and collaborative research and development agreement. Under the terms of the Agreement, PBI has been licensed by TDI to manufacture and sell a highly innovative line of chemicals used in the preparation of tissues for scientific analysis.
A provocative new study has found that people who respond to stressful situations with angry facial expressions, rather than fearful expressions, are less likely to suffer such ill effects of stress as high blood pressure and high stress hormone secretion.
The H1N1 (swine) flu is blamed for 557 deaths in Brazil, "making it the country with the highest number of fatalities in the world from the disease," according to the country's health ministry, Agence France-Presse reports. "Brazil's health ministry said in a statement the government was freeing up one billion dollars to buy 73 million doses of a new vaccine being developed against swine flu, as well as Tamiflu stocks, hospital equipment and diagnostic gear," the news service writes (8/26).
Exelixis, Inc. announced today that thirteen abstracts related to the company's development candidates have been accepted for presentation at the 2009 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics, which is being held November 15-19 in Boston. Interim data from ongoing phase 1 clinical trials of XL147 and XL765 will be reported in four poster presentations.
Scientists in The Netherlands have revealed how gluten plays a role in the development of a rare form of cancer, for some people with coeliac disease.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jon G Meine, MD 6000 W Creek Rd, Suite 10, Independence, OH 44131-2139 Ph: (800) 223-2273 | Jon G Meine, MD 9500 Euclid Ave, Cleveland, OH 44195-0001 Ph: (800) 223-2273 |
News Archive
Pressure BioSciences, Inc. and Target Discovery, Inc.,, today announced a strategic product licensing, manufacturing, co-marketing, and collaborative research and development agreement. Under the terms of the Agreement, PBI has been licensed by TDI to manufacture and sell a highly innovative line of chemicals used in the preparation of tissues for scientific analysis.
A provocative new study has found that people who respond to stressful situations with angry facial expressions, rather than fearful expressions, are less likely to suffer such ill effects of stress as high blood pressure and high stress hormone secretion.
The H1N1 (swine) flu is blamed for 557 deaths in Brazil, "making it the country with the highest number of fatalities in the world from the disease," according to the country's health ministry, Agence France-Presse reports. "Brazil's health ministry said in a statement the government was freeing up one billion dollars to buy 73 million doses of a new vaccine being developed against swine flu, as well as Tamiflu stocks, hospital equipment and diagnostic gear," the news service writes (8/26).
Exelixis, Inc. announced today that thirteen abstracts related to the company's development candidates have been accepted for presentation at the 2009 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics, which is being held November 15-19 in Boston. Interim data from ongoing phase 1 clinical trials of XL147 and XL765 will be reported in four poster presentations.
Scientists in The Netherlands have revealed how gluten plays a role in the development of a rare form of cancer, for some people with coeliac disease.
› Verified 7 days ago
Carol C Slover, MD Dermatology Medicare: Not Enrolled in Medicare Practice Location: 9500 Euclid Ave, Cleveland, OH 44195 Phone: 800-223-2273 | |
Wilma F Bergfeld, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 9500 Euclid Ave, Cleveland, OH 44195 Phone: 800-223-2273 | |
Antoine Amado De Olazaval, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 9500 Euclid Ave, Desk A61, Cleveland, OH 44195 Phone: 216-445-3643 Fax: 216-636-5151 | |
Katherine Camille Disano, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 2500 Metrohealth Dr, Cleveland, OH 44109 Phone: 216-778-5394 | |
Dr. John Scott Anthony, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 9500 Euclid Ave, St40, Cleveland, OH 44195 Phone: 440-878-2500 | |
Dr. Christine Jaworsky, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 2500 Metrohealth Dr, Cleveland, OH 44109 Phone: 216-778-7800 | |
Christine M Poblete-lopez, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 9500 Euclid Ave, Desk A61, Cleveland, OH 44195 Phone: 216-444-3345 |